Johnson & Johnson - Wikipedia, the free encyclopedia. Johnson & Johnson is an American multinationalmedical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 5. Johnson & Johnson is headquartered in New Brunswick, New Jersey, directly adjacent to the campus of Rutgers University, the consumer division being located in Skillman, New Jersey. The corporation includes some 2. Johnson & Johnson had worldwide sales of $6. Among its well- known consumer products are the Band- Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogenaskin and beauty products, Clean & Clear facial wash and Acuvuecontact lenses.
Matching gift companies Making a Difference Making a Difference back. Allen Family Foundation grant accelerated UMMS Ebola Relief effort Hudson Hoagland Society celebrates 30 years. Employer Matching Gifts Program. Generally, companies may. Johnson & Johnson.
History. The company produced its first products in 1. Robert Wood Johnson served as the first president of the company. He worked to improve sanitation practices in the nineteenth century, and lent his name to a hospital in New Brunswick, New Jersey.
Bank of America Matching Gifts Program. Johnson and Johnson Family of Companies Jones Lang LaSalle Americas JP Morgan Juniper Networks Matching Gift Companies This list is not all inclusive. List of Companies with Matching Gift Programs 4/30/2007 1 A. Bank of America Matching Gifts Program Bank of California, NA. Johnson & Johnson Family of Cos.
Upon his death in 1. James Wood Johnson until 1. Robert Wood Johnson II. Robert Wood Johnson's granddaughter, Mary Lea Johnson Richards, was the first baby to appear on a Johnson & Johnson baby powder label. In 1. 90. 4, one of Mc. Neil's sons, Robert Lincoln Mc.
Neil, became part of the company and together they created Mc. Neil Laboratories in 1. The company focused on direct marketing of prescription drugs to hospitals, pharmacists, and doctors. Development of acetaminophen began under the leadership of Robert L. Mc. Neil, Jr., who later served as the firm's chairman. In 1. 97. 7, two subsidiary companies were created; Mc. Neil medicals products and Mc.
Neil Consumer Products Company (also known as Mc. Neil Consumer Healthcare).
The focus of Mc. Neil medicals products is to market prescription drugs. In 1. 99. 3 Mc. Neil medicals products merged with the Ortho Pharmaceutical to form Ortho- Mc.
Neil Pharmaceutical. In 2. 00. 1 Mc. Neil Consumer Healthcare changed its name to Mc. Neil Consumer & Specialty medicals products. However, it was later changed to . The company markets over- the- counter and prescription medicals products including complete lines of Tylenol and Motrin IB (ibuprofen) products for adults and children. Cilag. This set the basis for the founding of Chemische Industrie- Labor AG (Chemical Industry Laboratory AG or Cilag) on 1.
Matching Gift Information. Many companies have a matching gift program which matches employee gifts to. Red Hat Matching Gifts Program. Reynolds American Foundation Rockefeller Family & Associates Rockefeller Financial. GENERAL PROVISIONS Through its Matching Gifts Program, the Johnson & Johnson Family of Companies Contribution Fund will donate two dollars to qualified nonprofit organizations for every one dollar an employee or retiree.
May 1. 93. 6. In 1. Cilag joined the Johnson & Johnson family of companies. In the early nineties the marketing organizations of Cilag and Janssen Pharmaceutica were joined to form Janssen- Cilag. The non- marketing activities of both companies still operate under their original name.
Cilag continues to have operations under the Cilag name in Switzerland, ranging from research and development through manufacturing and international services. In August 2. 01. 4 Cilag acquired Covagen a biopharmaceutical company which specialises in the development of multi- specific protein based therapeutics. As part of the acquisition Cilag wll gain access to Covagen.
In 1. 93. 3 Constant Janssen, the father of Paul Janssen, acquired the right to distribute the pharmaceutical products of Richter, a Hungarian pharmaceutical company, for Belgium, the Netherlands and Belgian Congo. On 2. 3 October 1. N. V. Produkten Richter in Turnhout. After the Second World War, the name for the company products was changed to Eupharma, although the company name Richter would remain until 1. On 5 April 1. 95. NV Laboratoria Pharmaceutica C.
Janssen (named after Constant Janssen). On 2 May 1. 95. 8, the research department in Beerse became a separate legal entity, the N. V. Research Laboratorium C. On 2. 4 October 1. American corporation Johnson & Johnson.
On 1. 0 February 1. Janssen Pharmaceutica N. V. Between 1. 99.
Janssen Pharmaceuticals expanded worldwide, with the company grew in size to approximately 2. In 1. 99. 9, clinical research and non- clinical development become a global organization within Johnson & Johnson. In 2. 00. 1, part of the research activities was transferred to the United States with the reorganization of research activities in the Johnson & Johnson Pharmaceutical Research and Development organization. The research activities of the Janssen Research Foundation and the R. W. Johnson Pharmaceutical Research Institute were merged into the new global research organization. On 2. 7 October 2.
Paul Janssen Research Center, for discovery research, was inaugurated. In August 2. 01. 3, the company acquired Aragon Pharmaceuticals, Inc. In November 2. 01. Alios Bio. Pharma, Inc. As a result of the purchase, Alios was incorporated into the infectious diseases therapeutic area of the Janssen Pharmaceutical Companies of Johnson & Johnson. On June 1. 4, 2. 01.
Johnson and Johnson completed the acquisition of Synthes for $1. In 1. 98. 2 Centocor transitioned into a publicly traded company. In 1. 99. 9, Centocor became a wholly owned subsidiary of Johnson & Johnson.
Since the acquisition, Janssen Biotech increased its annual sales from $5. During the same period, research and development investment increased from $7.
In 2. 00. 8, Centocor, Inc. In June 2. 01. 0 Centocor Ortho Biotech acquired Respi. Vert, a privately held drug discovery company focused on developing small- molecule, inhaled therapies for the treatment of pulmonary diseases. In December 2. 01.
Macro. Genics cancer drug candidate (MGD0. CD1. 9 and CD3 proteins in treating B- cell malignant tumours. This could net Macro. Genics up to $7. 00 million. Merson opened a facility in Edinburgh for the manufacturing, packaging and sterilising of catgut, silk and nylon sutures. Johnson & Johnson acquired Mr.
During the 1. 99. Ethicon diversified into new and advanced products and technologies and formed four different companies under the Ethicon umbrella, each of which specialize in different products. In 2. 00. 8 J& J announced it would acquire Mentor Corporation for $1 billion and merge its operations into Ethicon. Some of these subsidiaries include as follows: Baby.
Center, L. L. C. Children With Diabetes, Inc. Global Pharmaceutical Supply Group (GPSG)Groupe Vend. Cullen, Dominic Caruso, Michael M.
E. Johns, Ann Dibble Jordan, Arnold G. Mullin, William Perez, Steven S. Reinemund, David Satcher, and William C. The company considered moving its headquarters out of New Brunswick in the 1. New Brunswick by demolishing old buildings and constructing new ones. While New Brunswick lost at least one historic edifice (the inn where Rutgers University began) to the redevelopment, the gentrification did attract people back to New Brunswick.
Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design an addition to its headquarters. The white tower in a park across the railroad tracks from the older portion of the headquarters in one of tallest buildings in New Brunswick. The stretch of Delaware and Raritan canal by the company's headquarters was replaced by a stretch of Route 1. In 2. 01. 3, these segments contributed 3.
In 2. 01. 3, these two products accounted for 2. Johnson and Johnson's pharmaceutical revenues, and 1. A third immunology product, Stelara (ustekinumab), targets interleukin- 1.
Telaprevir sales are expected to decline due to the recent approval of treatment regimens that are more efficacious and much better tolerated. Etravirine and darunavir are notable for their high barriers to resistance development. Invega Sustenna and Risperdal Consta were the first widely utilized long- acting depot injections for the treatment of schizophrenia. Designed to address the issue of poor patient compliance with oral therapy, they are administered by intramuscular injection at intervals of 2 weeks and one month, respectively.
Only minimal improvements in outcomes relative to the oral versions of these drugs were observed in the clinical trial setting, but some evidence suggests that the advantages of long- acting injections in clinical practice may be greater than is readily demonstrated in the environment of a clinical trial. In clinical trials, abiraterone treatment was associated with a 4. The case remains unsolved and no suspects have been charged. Johnson & Johnson's quick response, including a nationwide recall, was widely praised by public relations experts and the media and was the gold standard for corporate crisis management. The recall was conducted after a routine inspection at a manufacturing facility in Fort Washington, Pennsylvania, United States revealed that some .
De. Puy said the recall was due to unpublished National Joint Registry data showing a 1. ASR XL revision rate of 1. All hip prostheses fail in some patients, but it is expected that the rate will be about 1% a year. Metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability. Ions of cobalt and chromium.
The judge initially dismissed the case in September 2. Food and Drug Administration (FDA) not to promote Risperdal as effective and safe for elderly patients, but they did so, and that they paid Omnicare to promote the drug to care home physicians. A clause in this law (now 1.
U. S. C. 7. 06) permits this pre- existing uses of the Red Cross to continue. A declaration made by the U. S. The American Red Cross continues to recognize the validity of Johnson & Johnson's trademark. The litigation was settled when Boston Scientific agreed to pay $7. Johnson & Johnson in September 2. February 2. 01. 0.
Johnson & Johnson claimed that Abbott used technology patented by New York University and licensed exclusively to Johnson & Johnson's Centocor division to develop Humira. Johnson & Johnson won the court case, and in 2. Abbott was ordered to pay Johnson & Johnson $1. J& J claimed that the safety of cosmetic talc is supported by decades of scientific evidence and it plans to appeal the verdict. The British charity, Ovacome was quoted as saying that while there were 1.